Bepridil [orch, phsu]
Drug [phsu]
Refractory [ftcn]
Ventricular tachyarrhythmia [patf]
discharges [bdsu]
Implantable Cardioverter-Defibrillators [medd]
Antiarrhythmic Drugs [phsu]
Needed [qlco]
Patients [podg]
Ventricular tachyarrhythmia [patf]
Ventricular tachyarrhythmia [patf]
Refractory [ftcn]
Conventional [qlco]
Antiarrhythmic Drugs [phsu]
Evaluated [ftcn]
Efficacy [qlco]
Bepridil [orch, phsu]
Multiple [qnco]
ion channel blocker [chvf]
Methods [inpr]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Ventricular tachyarrhythmia [patf]
Refractory [ftcn]
Multiple [qnco]
Antiarrhythmic Drugs [phsu]
Drugs [phsu]
Including [ftcn]
Class III [inpr]
Drugs [phsu]
Bepridil [orch, phsu]
prescribed [hlca]
Dose [qnco]
mg day [qnco]
Bepridil [orch, phsu]
Prolonged [tmco]
QT interval [clna]
QTC [qnco]
Affecting [ftcn]
heart rate [clna]
QRS duration [orga]
months [tmco]
Bepridil [orch, phsu]
Completely [qlco]
Suppressed [ftcn]
Ventricular tachyarrhythmia [patf]
Patients [podg]
Drug [phsu]
Decreased [qnco]
frequency [qnco]
Ventricular tachyarrhythmia [patf]
recurrences [phpr]
Patients [podg]
Marker [clna]
Complete [qlco]
Suppression [patf]
Ventricular tachyarrhythmia [patf]
Bepridil [orch, phsu]
treatment [ftcn]
included [ftcn]
Smaller [qlco]
Morphology [qlco]
NYHA Class [fndg]
Functional [ftcn]
Drug-induced [ftcn]
QT interval [clna]
QTC [qnco]
electrophysiologic study [diap]
Guide [prog]
Evaluation [ftcn]
Bepridil [orch, phsu]
Efficacy [qlco]
Bepridil [orch, phsu]
Patients [podg]
Bepridil [orch, phsu]
APPEAR [qlco]
suppress [ftcn]
Drug [phsu]
Refractory [ftcn]
Ventricular tachyarrhythmia [patf]
